Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
247
-
Total 13F shares, excl. options
-
28.5M
-
Shares change
-
+3.59M
-
Total reported value, excl. options
-
$5.23B
-
Value change
-
+$661M
-
Put/Call ratio
-
0.64
-
Number of buys
-
149
-
Number of sells
-
-107
-
Price
-
$183.64
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q2 2024
309 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q2 2024.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 247 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.5M shares
of 29.1M outstanding shares and own 98.02% of the company stock.
Largest 10 shareholders include FMR LLC (4.28M shares), BlackRock Inc. (3.95M shares), VANGUARD GROUP INC (2.87M shares), Avoro Capital Advisors LLC (2.43M shares), STATE STREET CORP (1.33M shares), Redmile Group, LLC (1.02M shares), Frazier Life Sciences Management, L.P. (988K shares), Capital World Investors (878K shares), PRICE T ROWE ASSOCIATES INC /MD/ (600K shares), and DIMENSIONAL FUND ADVISORS LP (580K shares).
This table shows the top 247 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.